08:00 , Nov 22, 2010 |  BC Week In Review  |  Company News

Astrimmune Ltd., London Genetics Ltd. deal

London Genetics partnered with Astrimmune to identify biomarkers that will identify patients most likely to benefit from Astrimmune's preclinical pancreatic cancer vaccine. Astrimmune said it is providing management and GI expertise, while London Genetics is...